Autoimmune Treatment Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Autoimmune Treatment Market to 2027 - Global Analysis and Forecasts By Application (Localized Autoimmune Diseases, Systemic Autoimmune Diseases); Drug Type (Anti-Inflammatory Drugs, Nonsteroidal Anti-Inflammatory Drugs, Immunosuppressant's, Corticosteroids, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography

Report Code: TIPRE00004203 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Autoimmune diseases or disorders refers to the diseases that are caused due to damage to the healthy cells. The healthy cells get disrupted or get damages by the one's own immune system. The most commonly seen autoimmune diseases are rheumatoid arthritis, lupus, celiac disease, multiple sclerosis, type 1 diabetes and others. The treatment for these diseases include medication that suppress the immune system.

MARKET DYNAMICS
The autoimmune treatment market is estimated to grow during the forecast period owing to the driving factors such as increasing expenditure for the product development, increasing genetic disorders, rising genetic disorders and disease across the world. The market is likely to witness growth opportunities due to the developments in the biotechnology industry.

MARKET SCOPE
The "Global Autoimmune Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of autoimmune treatment market with detailed market segmentation by application, drug type, distribution channel and geography. The global autoimmune treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading autoimmune treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global autoimmune treatment market is segmented on the basis of application, drug type and distribution channel. Based on the application the market is classified as localized autoimmune diseases and systemic autoimmune diseases. On the basis drug type the market is segmented as anti-inflammatory drugs, nonsteroidal anti-inflammatory drugs, immunosuppressant's, corticosteroids and others. And on the basis of the distribution channel the market is divided into hospital pharmacies and retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global autoimmune treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The autoimmune treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting autoimmune treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the autoimmune treatment market in these regions.

MARKET PLAYERS
The reports cover key developments in the autoimmune treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from autoimmune treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for autoimmune treatment market in the global market. Below mentioned is the list of few companies engaged in the autoimmune treatment market.

The report also includes the profiles of key autoimmune treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Amgen Inc
  • Janssen Global Services, LLC,(Johnson and Johson Services, Inc)
  • Active Biotech AB
  • Lupin Limited
  • Novartis AG
  • Eli Lilly and Company
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autoimmune Treatment Market - By Application
1.3.2 Autoimmune Treatment Market - By Drug Type
1.3.3 Autoimmune Treatment Market - By Distribution Channel
1.3.4 Autoimmune Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. AUTOIMMUNE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AUTOIMMUNE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AUTOIMMUNE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTOIMMUNE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. AUTOIMMUNE TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTOIMMUNE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. LOCALIZED AUTOIMMUNE DISEASES
7.3.1. Overview
7.3.2. Localized Autoimmune Diseases Market Forecast and Analysis
7.4. SYSTEMIC AUTOIMMUNE DISEASES
7.4.1. Overview
7.4.2. Systemic Autoimmune Diseases Market Forecast and Analysis
8. AUTOIMMUNE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANTI-INFLAMMATORY DRUGS
8.3.1. Overview
8.3.2. Anti-Inflammatory Drugs Market Forecast and Analysis
8.4. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
8.4.1. Overview
8.4.2. Nonsteroidal Anti-Inflammatory Drugs Market Forecast and Analysis
8.5. IMMUNOSUPPRESSANT'S
8.5.1. Overview
8.5.2. Immunosuppressant's Market Forecast and Analysis
8.6. CORTICOSTEROIDS
8.6.1. Overview
8.6.2. Corticosteroids Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. AUTOIMMUNE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
10. AUTOIMMUNE TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Autoimmune Treatment Market Overview
10.1.2 North America Autoimmune Treatment Market Forecasts and Analysis
10.1.3 North America Autoimmune Treatment Market Forecasts and Analysis - By Application
10.1.4 North America Autoimmune Treatment Market Forecasts and Analysis - By Drug Type
10.1.5 North America Autoimmune Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Autoimmune Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Autoimmune Treatment Market
10.1.6.1.1 United States Autoimmune Treatment Market by Application
10.1.6.1.2 United States Autoimmune Treatment Market by Drug Type
10.1.6.1.3 United States Autoimmune Treatment Market by Distribution Channel
10.1.6.2 Canada Autoimmune Treatment Market
10.1.6.2.1 Canada Autoimmune Treatment Market by Application
10.1.6.2.2 Canada Autoimmune Treatment Market by Drug Type
10.1.6.2.3 Canada Autoimmune Treatment Market by Distribution Channel
10.1.6.3 Mexico Autoimmune Treatment Market
10.1.6.3.1 Mexico Autoimmune Treatment Market by Application
10.1.6.3.2 Mexico Autoimmune Treatment Market by Drug Type
10.1.6.3.3 Mexico Autoimmune Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Autoimmune Treatment Market Overview
10.2.2 Europe Autoimmune Treatment Market Forecasts and Analysis
10.2.3 Europe Autoimmune Treatment Market Forecasts and Analysis - By Application
10.2.4 Europe Autoimmune Treatment Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Autoimmune Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Autoimmune Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Autoimmune Treatment Market
10.2.6.1.1 Germany Autoimmune Treatment Market by Application
10.2.6.1.2 Germany Autoimmune Treatment Market by Drug Type
10.2.6.1.3 Germany Autoimmune Treatment Market by Distribution Channel
10.2.6.2 France Autoimmune Treatment Market
10.2.6.2.1 France Autoimmune Treatment Market by Application
10.2.6.2.2 France Autoimmune Treatment Market by Drug Type
10.2.6.2.3 France Autoimmune Treatment Market by Distribution Channel
10.2.6.3 Italy Autoimmune Treatment Market
10.2.6.3.1 Italy Autoimmune Treatment Market by Application
10.2.6.3.2 Italy Autoimmune Treatment Market by Drug Type
10.2.6.3.3 Italy Autoimmune Treatment Market by Distribution Channel
10.2.6.4 Spain Autoimmune Treatment Market
10.2.6.4.1 Spain Autoimmune Treatment Market by Application
10.2.6.4.2 Spain Autoimmune Treatment Market by Drug Type
10.2.6.4.3 Spain Autoimmune Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Autoimmune Treatment Market
10.2.6.5.1 United Kingdom Autoimmune Treatment Market by Application
10.2.6.5.2 United Kingdom Autoimmune Treatment Market by Drug Type
10.2.6.5.3 United Kingdom Autoimmune Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Autoimmune Treatment Market Overview
10.3.2 Asia-Pacific Autoimmune Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Autoimmune Treatment Market Forecasts and Analysis - By Application
10.3.4 Asia-Pacific Autoimmune Treatment Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Autoimmune Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Autoimmune Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Autoimmune Treatment Market
10.3.6.1.1 Australia Autoimmune Treatment Market by Application
10.3.6.1.2 Australia Autoimmune Treatment Market by Drug Type
10.3.6.1.3 Australia Autoimmune Treatment Market by Distribution Channel
10.3.6.2 China Autoimmune Treatment Market
10.3.6.2.1 China Autoimmune Treatment Market by Application
10.3.6.2.2 China Autoimmune Treatment Market by Drug Type
10.3.6.2.3 China Autoimmune Treatment Market by Distribution Channel
10.3.6.3 India Autoimmune Treatment Market
10.3.6.3.1 India Autoimmune Treatment Market by Application
10.3.6.3.2 India Autoimmune Treatment Market by Drug Type
10.3.6.3.3 India Autoimmune Treatment Market by Distribution Channel
10.3.6.4 Japan Autoimmune Treatment Market
10.3.6.4.1 Japan Autoimmune Treatment Market by Application
10.3.6.4.2 Japan Autoimmune Treatment Market by Drug Type
10.3.6.4.3 Japan Autoimmune Treatment Market by Distribution Channel
10.3.6.5 South Korea Autoimmune Treatment Market
10.3.6.5.1 South Korea Autoimmune Treatment Market by Application
10.3.6.5.2 South Korea Autoimmune Treatment Market by Drug Type
10.3.6.5.3 South Korea Autoimmune Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Autoimmune Treatment Market Overview
10.4.2 Middle East and Africa Autoimmune Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Autoimmune Treatment Market Forecasts and Analysis - By Application
10.4.4 Middle East and Africa Autoimmune Treatment Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Autoimmune Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Autoimmune Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Autoimmune Treatment Market
10.4.6.1.1 South Africa Autoimmune Treatment Market by Application
10.4.6.1.2 South Africa Autoimmune Treatment Market by Drug Type
10.4.6.1.3 South Africa Autoimmune Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Autoimmune Treatment Market
10.4.6.2.1 Saudi Arabia Autoimmune Treatment Market by Application
10.4.6.2.2 Saudi Arabia Autoimmune Treatment Market by Drug Type
10.4.6.2.3 Saudi Arabia Autoimmune Treatment Market by Distribution Channel
10.4.6.3 U.A.E Autoimmune Treatment Market
10.4.6.3.1 U.A.E Autoimmune Treatment Market by Application
10.4.6.3.2 U.A.E Autoimmune Treatment Market by Drug Type
10.4.6.3.3 U.A.E Autoimmune Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Autoimmune Treatment Market Overview
10.5.2 South and Central America Autoimmune Treatment Market Forecasts and Analysis
10.5.3 South and Central America Autoimmune Treatment Market Forecasts and Analysis - By Application
10.5.4 South and Central America Autoimmune Treatment Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Autoimmune Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Autoimmune Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Autoimmune Treatment Market
10.5.6.1.1 Brazil Autoimmune Treatment Market by Application
10.5.6.1.2 Brazil Autoimmune Treatment Market by Drug Type
10.5.6.1.3 Brazil Autoimmune Treatment Market by Distribution Channel
10.5.6.2 Argentina Autoimmune Treatment Market
10.5.6.2.1 Argentina Autoimmune Treatment Market by Application
10.5.6.2.2 Argentina Autoimmune Treatment Market by Drug Type
10.5.6.2.3 Argentina Autoimmune Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. AUTOIMMUNE TREATMENT MARKET, KEY COMPANY PROFILES
12.1. F. HOFFMANN-LA ROCHE LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AMGEN INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JANSSEN GLOBAL SERVICES, LLC (JOHNSON AND JOHNSON SERVICES, INC)
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ACTIVE BIOTECH AB
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LUPIN LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVARTIS AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ELI LILLY AND COMPANY
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche Ltd
2. Pfizer Inc.
3. AstraZeneca
4. Bristol-Myers Squibb Company
5. Amgen Inc
6. Janssen Global Services, LLC,(Johnson and Johnson Services, Inc)
7. Active Biotech AB
8. Lupin Limited
9. Novartis AG
10. Eli Lilly and Company